243 related articles for article (PubMed ID: 29394027)
1. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
3. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
5. Titanium complexes in cancer treatment.
Meléndez E
Crit Rev Oncol Hematol; 2002 Jun; 42(3):309-15. PubMed ID: 12050022
[TBL] [Abstract][Full Text] [Related]
6. Copper Complexes in Cancer Therapy.
Denoyer D; Clatworthy SAS; Cater MA
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394035
[TBL] [Abstract][Full Text] [Related]
7. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
8. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
9. Titanium and vanadium complexes as anticancer agents.
Kostova I
Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167
[TBL] [Abstract][Full Text] [Related]
10. New insights on the active species and mechanism of cytotoxicity of salan-Ti(IV) complexes: a stereochemical study.
Manna CM; Armony G; Tshuva EY
Inorg Chem; 2011 Oct; 50(20):10284-91. PubMed ID: 21923127
[TBL] [Abstract][Full Text] [Related]
11. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
[TBL] [Abstract][Full Text] [Related]
12. Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.
Pesch T; Schuhwerk H; Wyrsch P; Immel T; Dirks W; Bürkle A; Huhn T; Beneke S
BMC Cancer; 2016 Jul; 16():469. PubMed ID: 27412346
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.
Ganot N; Briaitbard O; Gammal A; Tam J; Hochman J; Tshuva EY
ChemMedChem; 2018 Nov; 13(21):2290-2296. PubMed ID: 30203598
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands.
Immel TA; Groth U; Huhn T
Chemistry; 2010 Mar; 16(9):2775-89. PubMed ID: 20104550
[TBL] [Abstract][Full Text] [Related]
15. Bioanalytical and biophysical techniques for the elucidation of the mode of action of metal-based drugs.
Groessl M; Dyson PJ
Curr Top Med Chem; 2011; 11(21):2632-46. PubMed ID: 22039868
[TBL] [Abstract][Full Text] [Related]
16. Using titanium complexes to defeat cancer: the view from the shoulders of titans.
Cini M; Bradshaw TD; Woodward S
Chem Soc Rev; 2017 Feb; 46(4):1040-1051. PubMed ID: 28124046
[TBL] [Abstract][Full Text] [Related]
17. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
18. Antitumor titanium compounds.
Caruso F; Rossi M
Mini Rev Med Chem; 2004 Jan; 4(1):49-60. PubMed ID: 14754443
[TBL] [Abstract][Full Text] [Related]
19. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
[TBL] [Abstract][Full Text] [Related]
20. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin.
Tinoco AD; Eames EV; Incarvito CD; Valentine AM
Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
